← Browse by Condition
Medical Condition

chronic obstructive pulmonary disease

Total Trials
14
Recruiting Now
14
Trial Phases
Phase 3, Phase 1, Phase 4

ClinicalMetric tracks all active clinical trials for chronic obstructive pulmonary disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic obstructive pulmonary disease Clinical Trials

How many clinical trials are currently recruiting for chronic obstructive pulmonary disease?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for chronic obstructive pulmonary disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic obstructive pulmonary disease?
chronic obstructive pulmonary disease research spans Phase 1 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic obstructive pulmonary disease clinical trial?
Eligibility criteria for chronic obstructive pulmonary disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 3
1
Phase 4
1
Top Sponsors
Seattle Institute for Biomedical and Clinical Research 1 trial
Fu Jen Catholic University 1 trial
Assistance Publique - Hôpitaux de Paris 1 trial
University of Vermont 1 trial
University of Nebraska 1 trial

Recruiting Clinical Trials

NCT06390345
Recruiting
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
Enrollment
400 pts
Location
United States
Sponsor
Seattle Institute for Biomedic...
View Trial →
NCT07474220
Recruiting
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
Enrollment
180 pts
Location
Taiwan
Sponsor
Fu Jen Catholic University
View Trial →
NCT05844462 Phase 3
Recruiting
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Enrollment
200 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06432972
Recruiting
Accelerated Pulmonary Rehabilitation in the Preoperative Period
Enrollment
20 pts
Location
United States
Sponsor
University of Vermont
View Trial →
NCT06524856
Recruiting
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
Enrollment
20 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT03945968
Recruiting
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Enrollment
16,000 pts
Location
Russia
Sponsor
Russian Federation of Anesthes...
View Trial →
NCT06068647
Recruiting
Ultrasound and Respiratory Physiological Signals in Lung Diseases
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT06335992
Recruiting
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Enrollment
80 pts
Location
Sweden
Sponsor
Uppsala University
View Trial →
NCT07656142
Recruiting
A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease
Enrollment
240 pts
Location
China
Sponsor
Tiantian Li
View Trial →
NCT07762573
Recruiting
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
Enrollment
2,500 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →
NCT06670443
Recruiting
Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients
Enrollment
60 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT02966665 Phase 1
Recruiting
: Vascular Function in Health and Disease
Enrollment
420 pts
Location
United States
Sponsor
D. Walter Wray
View Trial →
NCT07579052
Recruiting
CLEAR Model for Predicting Ventilatory Liberation in Severe COPD
Enrollment
400 pts
Location
Egypt
Sponsor
Assiut University
View Trial →
NCT06334575 Phase 4
Recruiting
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Enrollment
135 pts
Location
Germany, Netherlands...
Sponsor
Maria Joyera Rodríguez
View Trial →

Related Conditions

obstructive sleep apnea (1) overweight and obesity (1) pulmonary hypertension (1) lung cancer (1) dyspnea (1) asthma (1) coronary heart disease (1) anemia (1) bronchial asthma (1) stroke (1) epilepsy (1) parkinson s disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology